Evidence map›Paper›PMID 40924452›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Excitatory glycine receptors control ventral hippocampus synaptic plasticity and anxiety-related behaviors.

Lara Pizzamiglio, Elise Morice, Cécile Cardoso, Simon Bossi, Caroline Mailhes-Hamon, Moritz von Heimendahl, Gabrielle Girardeau, Pierre Paoletti

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lara PizzamiglioInstitut de Biologie de l'Ecole Normale Supérieure, Ecole Normale Supérieure, Université Paris Sciences et Lettres, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Paris 75005, France.ORCID 0000-0003-4723-8510
Elise MoriceInstitut du Fer à Moulin, Institut National de la Santé et de la Recherche Médicale, Sorbonne Université, Paris 75005, France.
Cécile CardosoInstitut de Biologie de l'Ecole Normale Supérieure, Ecole Normale Supérieure, Université Paris Sciences et Lettres, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Paris 75005, France.ORCID 0000-0003-4491-5686
Simon BossiInstitut de Biologie de l'Ecole Normale Supérieure, Ecole Normale Supérieure, Université Paris Sciences et Lettres, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Paris 75005, France.ORCID 0000-0001-6411-5075
Caroline Mailhes-HamonInstitut de Biologie de l'Ecole Normale Supérieure, Ecole Normale Supérieure, Université Paris Sciences et Lettres, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Paris 75005, France.ORCID 0000-0002-7009-7798
Moritz von HeimendahlCentral Nervous System Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss 88397, Germany.
Gabrielle GirardeauInstitut du Fer à Moulin, Institut National de la Santé et de la Recherche Médicale, Sorbonne Université, Paris 75005, France.
Pierre PaolettiInstitut de Biologie de l'Ecole Normale Supérieure, Ecole Normale Supérieure, Université Paris Sciences et Lettres, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Paris 75005, France.ORCID 0000-0002-3681-4845

Funding

Agence Nationale de la Recherche (ANR) ANR EXCIGLYBoehringer Ingelheim (Boehringer Ingelheim International GmbH) Collaboration contract BI-ENSEC | European Research Council (ERC) NMDADYN #693021Fondation Schlumberger pour l'Education et la Recherche (FSER) FSERVille de Paris program Emergence(s)
6 · The paper itself

Abstract

Excitatory glycine receptors (eGlyRs), composed of the glycine-binding NMDA receptor subunits GluN1 and GluN3A, have recently emerged as a novel neuronal signaling modality that challenges the traditional view of glycine as an inhibitory neurotransmitter. Unlike conventional GluN1/GluN2 NMDARs, the distribution and role of eGlyRs remain poorly understood. Here, we show that eGlyRs are highly enriched in the ventral hippocampus (VH) and confer distinct properties on this brain region. eGlyRs display a massive expression in both VH CA1 pyramidal cells and SST- and PV-positive interneurons, whereas in the dorsal hippocampus (DH) pyramidal cells lack these receptors. eGlyRs mediate excitatory tonic currents and control VH network excitability. They are also responsible for the attenuated long-term potentiation (LTP) in the VH compared with the DH, providing a molecular basis for this difference. Furthermore, eGlyRs are required for regulation of VH LTP by corticosterone, pointing to eGlyRs as mediators of the neuroendocrine stress response. Consistent with this pervasive influence in the ventral division of the hippocampus, eGlyRs contribute to the modulation of anxiety-related behaviors. Our work identifies eGlyRs as key players in VH circuitry and function, demonstrating their intimate association with brain regions that control internal states and emotional processing.

Indexed as

AnxietyHippocampusNeuronal PlasticityReceptors, GlycineAnimalsBehavior, AnimalCA1 Region, HippocampalCorticosteroneInterneuronsLong-Term PotentiationMaleMiceMice, Inbred C57BLPyramidal CellsReceptors, N-Methyl-D-AspartateCorticosteroneReceptors, GlycineReceptors, N-Methyl-D-AspartateGluN3AglycineneurotransmissionNMDA receptorsventral hippocampus

Identifiers

PMID40924452
PMCPMC12452925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.